Luo Z, Wan Z, Ren P, Zhang B, Huang Y, West RE 3rd, Huang H, Chen Y, Nolin TD, Xie W, Wang J, Li S, Sun J. In Situ Formation of Fibronectin-Enriched Protein Corona on Epigenetic Nanocarrier for Enhanced Synthetic Lethal Therapy. Adv Sci (Weinh). 2024 Mar 14:e2307940. doi: 10.1002/advs.202307940. Epub ahead of print. PMID: 38482976.

Zhuoya Wan, Haozhe Huang, Raymond E. West III, Min Zhang, Bei Zhang, Xinran Cai, Ziqian Zhang, Zhangyi Luo, Yuang Chen, Yue Zhang, Wen Xie, Da Yang, Thomas D. Nolin, Junmei Wang, Song Li, Jingjing Sun. Overcoming pancreatic cancer immune resistance by codelivery of CCR2 antagonist using a STING-activating gemcitabine-based nanocarrier, Materials Today, Volume 62, 2023, Pages 33-50, ISSN 1369-7021.

https://www.sciencedirect.com/science/article/pii/S1369702122002978

Moharil P, Wan Z, Pardeshi A, Li J, Huang H, Luo Z, Rathod S, Zhang Z, Chen Y, Zhang B, Fernandez C, Sun J*, Li S*. Engineering a folic acid-decorated ultrasmall gemcitabine nanocarrier for breast cancer therapy: Dual targeting of tumor cells and tumor-associated macrophages. Acta Pharmaceutica Sinica B, 2022, 12, 1148-1162.

https://www.sciencedirect.com/science/article/pii/S221138352100383X

Sun J*, Wan Z, Xu J, Luo Z, Ren P, Zhang B, Diao D, Huang Y, Li S*. Tumor size-dependent abscopal effect of polydopamine-coated all-in-one nanoparticles for immunochemo-photothermal therapy of early- and late-stage metastatic cancer. Biomaterials, 2021, 269, 120629.

https://www.sciencedirect.com/science/article/abs/pii/S0142961220308760

Sun J*, Chen Y, Xu J, Song X, Wan Z, Du Y, Ma W, Li X, Zhang L, Li S*. High loading of hydrophobic and hydrophilic agents via small immunostimulatory carrier for enhanced tumor penetration and combinational therapy. Theranostics, 2020, 10, 1136-1150.

https://www.thno.org/v10p1136.htm

Sun J*, Wan Z, Chen Y, Xu J, Luo Z, Parise RA, Diao D, Ren P, Beumer JH, Lu B, Li S*. Triple drugs co-delivered by a small gemcitabine-based carrier for pancreatic cancer immunochemotherapy. Acta Biomaterialia, 2020, 106, 289-300.

https://www.sciencedirect.com/science/article/abs/pii/S1742706120300544

Luo Z, Xu J, Sun J, Huang H, Zhang Z, Ma W, Wan Z, Liu Y, Pardeshi A, Li S*. Co-delivery of 2-deoxyglucose and a glutamine metabolism inhibitor V9302 via a prodrug micellar formulation for synergistic targeting of metabolism in cancer. Acta Biomaterialia, 2020, 105, 239-252.

https://www.sciencedirect.com/science/article/abs/pii/S1742706120300337

Updates

Publications.

Updates

Publications.

In Situ Formation of Fibronectin-Enriched Protein Corona on Epigenetic Nanocarrier for Enhanced Synthetic Lethal Therapy Item

Overcoming pancreatic cancer immune resistance by codelivery of CCR2 antagonist using a STING-activating gemcitabine-based nanocarrier

Engineering a folic acid-decorated ultrasmall gemcitabine nanocarrier for breast cancer therapy: Dual targeting of tumor cells and tumor-associated macrophages.

Tumor size-dependent abscopal effect of polydopamine-coated all-in-one nanoparticles for immunochemo-photothermal therapy of early- and late-stage metastatic cancer.

High loading of hydrophobic and hydrophilic agents via small immunostimulatory carrier for enhanced tumor penetration and combinational therapy.

Triple drugs co-delivered by a small gemcitabine-based carrier for pancreatic cancer immunochemotherapy.

Co-delivery of 2-deoxyglucose and a glutamine metabolism inhibitor V9302 via a prodrug micellar formulation for synergistic targeting of metabolism in cancer.